Aida Pharmaceuticals Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AIDA has 27.00 million shares outstanding.
| Current Share Class | 27.00M |
| Shares Outstanding | 27.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 0.00 |
| P/OCF Ratio | 0.00 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 2.37.
| Current Ratio | 0.73 |
| Quick Ratio | 0.46 |
| Debt / Equity | 2.37 |
| Debt / EBITDA | 4.33 |
| Debt / FCF | 15.98 |
| Interest Coverage | 2.56 |
Financial Efficiency
Return on equity (ROE) is -1.79% and return on invested capital (ROIC) is 8.11%.
| Return on Equity (ROE) | -1.79% |
| Return on Assets (ROA) | 6.62% |
| Return on Invested Capital (ROIC) | 8.11% |
| Return on Capital Employed (ROCE) | 23.72% |
| Revenue Per Employee | 90,011 |
| Profits Per Employee | -4,841 |
| Employee Count | 450 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 3.66 |
Taxes
| Income Tax | -1.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 19.79 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 41.45 |
| Average Volume (20 Days) | 11,514 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIDA had revenue of 40.51 million and -2.18 million in losses. Loss per share was -0.08.
| Revenue | 40.51M |
| Gross Profit | 22.30M |
| Operating Income | 7.02M |
| Pretax Income | -1.39M |
| Net Income | -2.18M |
| EBITDA | 9.51M |
| EBIT | 7.02M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 8.28 million in cash and 41.17 million in debt, giving a net cash position of -32.90 million or -1.22 per share.
| Cash & Cash Equivalents | 8.28M |
| Total Debt | 41.17M |
| Net Cash | -32.90M |
| Net Cash Per Share | -1.22 |
| Equity (Book Value) | 17.34M |
| Book Value Per Share | 0.34 |
| Working Capital | -12.09M |
Cash Flow
In the last 12 months, operating cash flow was 7.49 million and capital expenditures -4.92 million, giving a free cash flow of 2.58 million.
| Operating Cash Flow | 7.49M |
| Capital Expenditures | -4.92M |
| Free Cash Flow | 2.58M |
| FCF Per Share | 0.10 |
Margins
Gross margin is 55.06%, with operating and profit margins of 17.34% and -5.38%.
| Gross Margin | 55.06% |
| Operating Margin | 17.34% |
| Pretax Margin | -3.43% |
| Profit Margin | -5.38% |
| EBITDA Margin | 23.49% |
| EBIT Margin | 17.34% |
| FCF Margin | 6.36% |
Dividends & Yields
AIDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.65% |
| Shareholder Yield | n/a |
| Earnings Yield | -40,343.13% |
| FCF Yield | 47,701.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AIDA has an Altman Z-Score of 1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1 |
| Piotroski F-Score | 5 |